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Abstract
Background: The NDI, COM and NPQ are evaluation instruments for disability due to NP. There
was no Spanish version of NDI or COM for which psychometric characteristics were known. The
objectives of this study were to translate and culturally adapt the Spanish version of the Neck
Disability Index Questionnaire (NDI), and the Core Outcome Measure (COM), to validate its use
in Spanish speaking patients with non-specific neck pain (NP), and to compare their psychometric
characteristics with those of the Spanish version of the Northwick Pain Questionnaire (NPQ).
Methods: Translation/re-translation of the English versions of the NDI and the COM was done
blindly and independently by a multidisciplinary team. The study was done in 9 primary care
Centers and 12 specialty services from 9 regions in Spain, with 221 acute, subacute and chronic
patients who visited their physician for NP: 54 in the pilot phase and 167 in the validation phase.
Neck pain (VAS), referred pain (VAS), disability (NDI, COM and NPQ), catastrophizing (CSQ) and
quality of life (SF-12) were measured on their first visit and 14 days later. Patients' self-assessment
was used as the external criterion for pain and disability. In the pilot phase, patients' understanding
of each item in the NDI and COM was assessed, and on day 1 test-retest reliability was estimated
by giving a second NDI and COM in which the name of the questionnaires and the order of the
items had been changed.
Results:  Comprehensibility of NDI and COM were good. Minutes needed to fill out the
questionnaires  [median, (P25, P75)]: NDI. 4 (2.2, 10.0), COM: 2.1 (1.0, 4.9). Reliability: [ICC,
(95%CI)]: NDI: 0.88 (0.80, 0.93). COM: 0.85 (0.75,0.91). Sensitivity to change: Effect size for patients
having worsened, not changed and improved between days 1 and 15, according to the external
criterion for disability: NDI: -0.24, 0.15, 0.66; NPQ: -0.14, 0.06, 0.67; COM: 0.05, 0.19, 0.92. Validity:
Results of NDI, NPQ and COM were consistent with the external criterion for disability, whereas
only those from NDI were consistent with the one for pain. Correlations with VAS, CSQ and SF-
12 were similar for NDI and NPQ (absolute values between 0.36 and 0.50 on day 1, between 0.38
and 0.70 on day 15), and slightly lower for COM (between 0.36 and 0.48 on day 1, and between
0.33 and 0.61 on day 15). Correlation between NDI and NPQ: r = 0.84 on day 1, r = 0.91 on day
15. Correlation between COM and NPQ: r = 0.63 on day 1, r = 0.71 on day 15.
Conclusion: Although most psychometric characteristics of NDI, NPQ and COM are similar,
those from the latter one are worse and its use may lead to patients' evolution seeming more
positive than it actually is. NDI seems to be the best instrument for measuring NP-related disability,
since its results are the most consistent with patient's assessment of their own clinical status and
evolution. It takes two more minutes to answer the NDI than to answer the COM, but it can be
reliably filled out by the patient without assistance.
Trial Registration: Clinical Trials Register NCT00349544.
Background
Mechanical, non-specific or common neck pain (NP) may
have an impact on the functional status of the patient,
interfering with basic activities such as sleeping or per-
sonal care, as well as on many work-related activities. In
fact, NP is a common cause of disability and work absen-
teeism [1].
Although pain may lead to disability, those are two differ-
ent dimensions that should be assessed separately [2]. In
the research environment, reliable and valid instruments
to measure NP-related disability are needed to assess the
effect of treatment on that variable. In clinical practice, it
is important to reliably measure disability since it influ-
ences a patient's quality of life, work absenteeism and per-
sonal and societal costs. Early monitoring and accurate
follow-up of disability are also useful for identifying
This article is available from: http://www.biomedcentral.com/1471-2474/9/42
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patients at higher risk for chronic disability and for decid-
ing treatment goals and methods at any given time. In
order to be recommended, instruments for measuring dis-
ability should be accurate and reliable. To be used in prac-
tice, these instruments should not reduce consultation
time, i.e., they should be simple and easy to score by the
physician, and easily understood by the patients, who can
answer the questionnaires in the waiting room without
assistance.
The Neck Disability Index (NDI) and the Northwich Park
Questionnaire are two questionnaires for measuring NP-
related disability [3,4]. Both questionnaires derive from
the Oswestry Disability Index for measuring low back
pain-related disability [5], and were designed to be filled
out directly by the patient. They consist of 10 items reflect-
ing activities of daily living or impairments that can be
influenced by NP. For each dimension, six possible
answers are provided. The patient must mark the answer
that better describes his/her current status. Option 1
scores 0 points and represents no limitation for that par-
ticular activity, whereas option 6 scores 5 points and rep-
resents the maximum possible limitation (Appendix 1).
Therefore, the maximum possible score is 50. However,
results are usually given as the percentage of that maxi-
mum possible score, so the range from best to worst is
0–100.
Dimensions explored in the NPQ are neck pain intensity,
interference of neck pain with sleep, interference with
sleep of pins and needles or numbness in the arms at
night, duration of symptoms, carrying objects, reading
and watching television, working and/or doing house-
work, social activities, driving and a comparison of cur-
rent state with the last time the questionnaire was
completed [4]. Dimensions explored in the NDI are neck
pain intensity, personal care (washing, dressing, etc.), lift-
ing, reading, headache, concentration, work, driving,
sleeping and recreation [3]. The NDI is one of the most
used scales for measuring NP-related disability, and it has
been successfully translated into French [6], Brazilian Por-
tuguese [7], Korean [8], and Turkish [9]. Additionally, a
modified Swedish version also exists [10].
The Core Outcome Measure (COM) was first proposed as
a set of outcome measures for low back pain patients [11].
An adaptation for neck pain patients was developed later,
and has been assessed in patients with common neck pain
and in those with whiplash [12,13]. It includes the follow-
ing dimensions: "severity of pain" (questions 1a -on neck
pain- and 1b -on pain referred to the shoulder or arm-),
"function" (question 2), "well-being" (question 3), "disa-
bility" (question 4), "absenteeism" (question 5) and "sat-
isfaction" (question 6). Each item has 5 possible answers.
Answers for items 3 and 6 are ordered from worst to best,
while the rest is ordered from best to worst. (Appendix 2)
The final score is the mean of the scores for each item, so
to obtain it, the order of answers for items 3 and 6 must
first be reversed. The final score ranges from 1.0 (best pos-
sible state) to 5.0 (worst possible state) [11-13].
However, only a modified Spanish version of the NPQ
existed for measuring NP-related disability in Spanish
speaking patients [14], and there was no Spanish version
of the NDI or COM for which psychometric characteristics
were known.
Therefore, the objectives of this study were: 1) To translate
into Spanish and culturally adapt the NDI and COM, 2)
to validate their use among Spanish neck pain patients, 3)
to compare their psychometric characteristics with those
of the NPQ.
Methods
Study design
The study was carried out in three phases: the first was
translation into Spanish and cultural adaptation of the
NDI and COM; the second was a pilot study to assess the
comprehensibility and reproducibility of those Spanish
versions; and the third was a validation study to deter-
mine their metric characteristics and to compare them
with those of the NPQ.
Translation phase
The same methods were followed separately for both the
NDI and COM questionnaires. Each questionnaire was
translated into Spanish by two different and independent
native Spanish speakers, who had no medical knowledge
and were both unaware of the purpose of the translation
and of the fact that another translator was doing the same
task. Both Spanish translations were then compared for
inconsistencies. The two translations were then retrans-
lated, also blindly and independently, into English by two
native English speakers. Each of the English translations
was then compared with the original English question-
naire and checked for inconsistencies.
The Spanish version of the questionnaire was then sepa-
rately reviewed and fine tuned by a bilingual team includ-
ing the four translators, eight primary care physicians,
four back specialists, and three methodologists (see Addi-
tional files 1 and 2).
Pilot phase
The pilot phase was performed in 15 Centers located in 7
different administrative regions, of the 17 existing in
Spain. All the Centers belong to the Spanish National
Health System and are involved in the Spanish Back Pain
Research Network. Participating Centers included 8 pri-BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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mary care centers and 7 hospital outpatient clinics in
orthopedic surgery, rheumatology and rehabilitation.
The pilot study was carried out with patients who con-
sulted their physician for NP between Oct 7, 2005, and
April 5, 2006. Inclusion criteria were consulting for NP,
with or without referred pain, being able to read Spanish
and signing the corresponding written informed consent.
The study was approved by the Ethics Commission of the
Hospital Parc Tauli (Sabadell, Barcelona) on Oct 5th,
2005.
Exclusion criteria were: functional illiteracy (mental status
insufficient to be able to complete the questionnaires),
treated or untreated central nervous system impairment,
direct trauma to the neck, and criteria for referral to sur-
gery or for suspecting a potential systemic disease. Criteria
for referral to surgery were defined as clinically relevant
motor weakness or disabling pain radiating down the arm
for at least 6 weeks in spite of conservative treatment,
caused by a nerve root compression demonstrated by
magnetic resonance (MRI) or computed tomography
(CT) studies. Reasons for suspecting a potential underly-
ing systemic disease were defined as oncologic disease
during the previous 5 years, constitutional symptoms -
unexplained weight loss, fever, chills-, history of intrave-
nous drug use, or immunocompromised host.
The sample size of the pilot study was established at 50
patients. According to the available evidence on low back
pain patients, the limit between acute and subacute pain
was established at 14 days [2,15], and the limit between
subacute and chronic at 90 days.16
Patients were seen the day of admission to the study (day
1) and 14 days later (day 15). At the first visit, the follow-
ing variables were recorded on the data collection form:
sex, age, socioeconomic level, family situation, academic
level, work status, duration of the current work status,
chronicity of pain (defined as acute, subacute or chronic)
[2,15,16], patients' subjective assessments of severity of
pain (no pain, mild, moderate, severe, unbearable) and of
degree of limitations in daily living due to neck pain
(none, mildly limited, moderately, severely, or very
severely limited). Those patients' subjective assessments
were considered as the "external criterion" for severity of
pain and disability, respectively.
In addition, diagnostic procedures and treatments that
patients had undergone were recorded, and those subjects
in whom cervical disc herniations had been observed on
MRI or CT scans were identified (Table 1).
At both visits, patients were given two separate Visual Ana-
logue Scales (VAS) [17] for measuring neck pain and pain
referred to the arm, the NDI, COM and NPQ question-
naires to assess neck pain-related disability, the previously
validated Spanish versions of the SF-12 questionnaire for
measuring general quality of life [18], and the Coping
Strategies Questionnaire (CSQ) [19,20] to assess catastro-
phizing thoughts. VAS values range from better to worse,
from 0 to 10, and CSQ from 0 to 36 [17,19,20]. Within
the SF-12 two subscales are defined: the physical compo-
nent summary (PCS-SF12) and the mental component
summary (MCS-SF12). Higher scores reflect better quality
of life, and values have been normalized so that mean val-
ues on both subscales for the Spanish population are 50,
and SD is 10. Values range from 19.85 to 56.71 for PCS-
SF12, and from 14.15 to 68.45 for MCS-SF12 [18].
All self-assessment questionnaires were given by adminis-
trative staff and the patients filled them out on their own
and alone, without the presence of staff or accompanying
persons. Requests for aid in interpretation of the items in
the NDI and COM questionnaires were registered. The
completed instruments were then given to the treating
physician, who stapled scales and questionnaires onto the
patient's data collection form.
Patients were told that several questionnaires were going
to be given, and were asked to notify the staff in case that
any of them was given twice. On day 1, each patient was
given a first NDI and COM questionnaire. The time
needed for answering each one was recorded. To assess
repeatability, patients were asked to fill out the VAS, RMQ
and SF12, and at least 30 min. after having answered the
NDI and COM the patient was given a second version of
those questionnaires. Questionnaires in this second set
were printed in differently colored paper, listed the items
in a different order and were not titled "NDI" and "COM",
but "NID" and "CSC6". Finally, the clinician filled out a
standardized questionnaire asking each patient about his
or her interpretation of the meaning of each of the items
in the NDI and the COM.
It was decided that sentences for which more than 10% of
patients in the pilot study needed clarification or misinter-
preted the meaning would be reviewed before undertak-
ing the validation study. Such review would be made by
the bilingual team that developed the first version, based
on the patients' suggestions and on the comments from
the clinicians administering the questionnaire and inter-
viewing the patients. It was also decided that if that team
felt that potential modifications in the questionnaire were
relevant enough, data gathered from patients included in
the pilot phase would not be used for the objectives of the
validation phase.
Data were entered in the database at a centralized coordi-
nation office. Entry of data was done independently by BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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Table 1: Characteristics of study participants.
Variable; n(%) N (%)
N = 221
Gender:
Female 172 (77.8)
Male 49 (22.2)
Age; median (SD) 48.7 (14.8)
Recruitment setting
Primary care 43 (19.5)
Specialized care 178(80.5)
Duration of current episode (days); median (P25;P75) 40.0 (15.0; 90.0)
Chronicity
Acute (1–14 days) 46 (20.8)
Subacute (14–90 days) 152 (68.8)
Chronic (> 90 days) 22 (10.0)
Missing 1 (0.5)
Family situation
Single 48 (21.7)
Married 131 (59.3)
Widowed 19 (8.6)
Divorced 21 (9.5)
Other 1 (0.5)
Missing 1 (0.5)
Academic level
Less than elementary school 21 (9.5)
Elementary school 81 (36.7)
High school 74 (33.5)
University 39 (17.6)
Missing 6 (2.7)
Working situation
Self-employed 23 (10.4)
Employed 121 (54.4)
Retired 34 (15.4)
Without work 6 (2.7)
Student 5 (2.3)
Housewife 24 (10.9)
Missing 8 (3.6)
External criterion for neck pain
No pain 7 (3.2)
Mild pain 74 (33.5)
Moderate pain 83 (37.6)
Severe pain 49 (22.2)
Very severe pain 8 (3.6)
External criterion for neck disability
None 7 (3.2)
Mild 56 (25.3)
Moderate 82 (37.1)
Severe 59 (26.7)
Very severe 16 (7.2)
Missing 1 (0.5)
X-rays
No 105 (47.5)
Yes 116 (52.5)
CT Scan
No 206 (93.2)
Yes 15 (6.8)BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
Page 6 of 13
(page number not for citation purposes)
two administrative assistants, who double-checked that
the data they were entering coincided with the scores of
the two VAS scales and the NPQ, NDI, NID, COM, CSC6,
CSQ, and SF-12 questionnaires.
Validation phase
The validation phase was performed in 12 Health Care
Centers from 7 different regions in Spain, including two
regions from which no Center had participated in the
pilot phase. Ten Centers belong to the Spanish National
Health System (SNHS) and two to not-for-profit Founda-
tions working for SNHS. All the Centers are involved in
the Spanish Back Pain Research Network. Participating
Centers included 3 primary care centers and 9 specialty
centers in rehabilitation, neuroreflexotherapy, orthopedic
MRI
No 176 (79.6)
Yes 45 (20.4)
Image of cervical disc herniation
No 177 (80.1)
Yes 42 (19.0)
Missing 2 (0.9)
Electromyography
No 210 (95.0)
Yes 11 (5.0)
Drug Treatment
No 29 (13.1)
Yes 192 (86.9)
Education (traditional biomechanic)
No 199 (90.0)
Yes 21 (9.5)
Missing 1 (0.5)
Education (active management)
No 214 (96.8)
Yes 7 (3.2)
Physiotherapy (passive)
No 182 (82.4)
Yes 39 (17.6)
Exercise
No 196 (88.7)
Yes 25 (11.3)
Rehabilitation
No 208 (94.1)
Yes 13 (5.9)
NRT intervention
No 195 (88.2)
Yes 26 (11.8)
Epidural injections
No 219 (99.1)
Yes 2 (0.9)
Facet joint denervation
No 216 (97.7)
Yes 5 (2.3)
Surgery
No 219 (99.1)
Yes 2 (0.9)
Other treatments
No 204 (92.3)
Yes 17 (7.7)
Table 1: Characteristics of study participants. (Continued)BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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surgery, rheumatology and neurosurgery, five of which
did not participate in the pilot phase.
The validation study was carried out with subjects who
consulted for neck pain between April 6, 2006 and Feb 1,
2007. In order to ensure a sufficient number of acute, sub-
acute and chronic patients, the sample size was estab-
lished at 150 with a minimum of 15 in each of the three
subgroups (acute, subacute and chronic). The only differ-
ences with methods used in the pilot phase were: 1) the
time needed to fill out the NDI and COM was not regis-
tered, 2) only one version of the questionnaires was given
(NID and CSC6 were not used), and 3) patients were not
asked about their comprehension of each item in the
questionnaires.
Analysis
Comprehension was determined in the pilot study by the
patients' answers to the questions exploring their under-
standing of each item on the NDI and COM question-
naires, and was measured in both the pilot and validation
studies by the patients' requests for aid in interpretation
and by the number of items which were not answered in
each questionnaire.
The distribution of answers across categories was assessed
for each item, and potential ceiling and floor effects were
estimated by calculating the percentage of subjects indi-
cating the maximum and minimum possible scores for
the NDI, COM and NPQ questionnaires.
Sensitivity to change was estimated by calculating the
effect size of NDI, NPQ and COM in patients that, accord-
ing to external criteria for pain and disability, had wors-
ened, not changed or improved between days 1 and 15.
Worsening and improvement in pain and disability were
defined as any negative or positive change in the corre-
sponding external criterion. For each questionnaire, effect
size was calculated as the difference between scores on day
1 and 15, divided by the standard deviation of the score
on day 1. According to this method, an effect size < 0.20
corresponds to no change, 0.20–0.49 to a small change,
0.50 to 0.79 to a moderate change and ≥ 0.80 to a great
change [21-23].
Test-retest reliability was measured in the pilot phase,
comparing the results of the first and second NDIs, iden-
tified respectively as "NDI" and "NID", and the results of
the first and second COM, identified respectively as
"COM" and "CSC6". Reliability was assessed through the
kappa index for answers given to the same items in both
versions of each questionnaire. The reliability of the total
score was assessed through the intraclass correlation coef-
ficient [24] and the Bland-Altman method [25]. In addi-
tion, the total scores of both versions of the NDI were
classified as reflecting "no disability" (NDI < 10% of max-
imum total score), or a "mild" (NDI between 10% and <
30%), "moderate" (NDI between 30% and < 50%),
"severe" (NDI between 50% and < 70%) or "very severe"
(NDI >= 70%) degree of disability [2]. The kappa index
was used to compare those total scores. To that end, bi-
square weights [26] were used. Since results from the
COM are not categorized, this approach was only used for
NDI
Cronbach's alpha was used to evaluate internal consist-
ency of the NDI and NPQ [27]. Since COM aggregates sev-
eral subscales, Cronbach's alfa was calculated only for the
subscales on pain and disability of that questionnaire.
Validity was measured by Spearman's correlation coeffi-
cients between VAS, CSQ, PCS-SF12, MCS-SF12, NPQ,
NDI and COM values, for days 1 and 15 [17]. In addition,
median (P25, P75) total scores of NDI, COM and NPQ
were calculated for each category in the external criteria
for pain severity and disability.
Results
A total of 221 patients were eligible and none were
excluded. Fifty-four patients were recruited for the pilot
study and 167 for the validation study. Forty-two (19.0%)
showed images of cervical disc herniation on MRI. For the
pilot study, 23 patients were recruited from primary care
centers and 31 from the hospital setting. For the valida-
tion study, 20 patients were recruited from primary care
centers and 147 from the hospital setting (Table 1).
Table 1 shows the characteristics of the study subjects and
Table 2 shows values for scores on the VAS, NDI, COM,
NPQ and SF-12 for days 1 and 15. Since data are slightly
skewed, they are given as a median (P25, P75).
The time needed to fill out the Spanish version of the NDI
was 4 minutes (P25, P75: 2.2, 10.0), and for the Spanish
version of the COM, it was 2.1 min. (1.0, 4.9).
In relation to the NDI, at the end of the pilot phase 10
patients had asked for aid in the interpretation of ques-
tions No. 3 (4 patients, 7.4% of those participating in the
pilot phase), No. 8 (3 patients, 5.5%), No. 1 (2 patients,
3.7%), No. 2 (2 patients, 3.7%) No. 7 (1 patient, 1.9%)
and No. 9 (1 patient, 1.9%), with 4 patients asking for
help with two questions. In addition, 8 patients did not
answer question No. 8 because they did not drive. Only
four patients misunderstood the meaning of the following
questions: N° 4 (2 patients, 3.7%), No. 5 (1 patient,
1.9%) and No. 7 (1 patient, 1.9%).
In relation to the COM, 10 patients asked for aid in inter-
pretation of questions N° 6 (4 patients, 7.4%), No. 5 (4
patients, 7.4%), No. 4 (3 patients, 5.5%), No. 3 (2BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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patients, 3.7%), No. 2 (2 patients, 3.7%), No. 1b (1
patient, 1.9%) and No. 1a (1 patient, 1.9%), with one
patient requesting help with 4 questions, one with 3 ques-
tions and three with 2 questions. Only one patient (1.9%)
misunderstood the meaning of question No. 6. Therefore,
the wording of the NDI and COM remained unchanged
for the validation phase.
No patient notified the staff of having identified the NDI
and the NID questionnaires, or the COM and the CSC6,
as being the same. Cronbach's alfa was 0.89 for the NDI,
0.91 for the NID, 0.84 for the NPQ, 0.73 and 0.84 for the
pain and disability subscales of COM, respectively, and
0.62 and 0.90 for the pain and disability subscales of
CSC6, respectively.
In relation to the NDI, a comparison of the scores of both
versions of the questionnaire yielded the following results
[median (P25; P75)]: NDI: 36.9 (25.6; 51.8), NID: 35.0
(25.5; 46.2), with 68.5% of answers being identical in
both questionnaires, and an intraclass correlation coeffi-
cient for both of 0.88 (95% IC; 0.80, 0.93). The limits of
agreement between NDI and NID were 1.25 ± 18.33 (see
Additional file 3). The mean of bi-square weighted kappa
values for all items was 0.84. Six items had a substantial
concordance of 0.61–0.80 (Nos. 3, 4, 6, 7, 8 and 10), and
four (Nos. 1, 2, 5 and 9) an almost perfect concordance
greater than 0.80 [28].
In relation to the COM, a comparison of the scores of
both versions of the questionnaire yielded the following
results [median (P25; P75)]: COM: 3.0 (2.6; 3.5), CSC6:
2.8 (2.6; 3.4), with 76.4% of answers being identical in
both questionnaires, and an intraclass correlation coeffi-
cient for both of 0.85 (95% IC; 0.75, 0.91). One item had
a moderate concordance of 0.54 (No. 6), two a substantial
concordance of between 0.61 and 0.80 (Nos. 1a and 3),
and four (Nos. 1b, 2, 4 and 5) an almost perfect concord-
ance greater than 0.80 [28]. The limits of agreement
between COM and CSC6 were 0.04 ± 0.76 (see Additional
file 3).
All of the items of NDI, NPQ and COM had answers dis-
tributed across all categories. For the NDI, the lowest
observed score was 4% (rated by 1 patient, 0.5% of the
221 subjects participating in the study), and the highest
one was 86% (rated by 1 patient, 0.5%). For the COM, the
lowest observed score was 1.2 points (rated by 2 patients,
0.9%) and the highest one was 5.0 (1 patients, 0.5%). For
the NPQ, the lowest observed score was 5.6% (1 patient,
0.5%), and the highest was 84.4% (1 patient, 0.5%)
(Table 3).
Results of NDI, NPQ and COM were consistent with the
external criterion for disability, so that values for those
questionnaires were higher as patient's self-perception of
disability increased (Table 5). However, only results of the
NDI were consistent with the external criterion for pain
(Table 4). For NPQ, values were identical for subjects in
the categories "severe pain" and "very severe pain". For
COM, values were identical for patients in the "mild pain"
and "moderate pain" categories, and were higher for those
in the "severe pain" category than for those in the "very
severe pain" category (Table 4).
Table 3: Maximum and Minimum Scores: Floor and Ceiling Effects.
Minimum Score Recorded Patients With Minimum Score (Floor Effect) Maximum Score Recorded Patients With Maximum Score (Ceiling Effect)
NDI 4.0 1 (0.5%) 86.0 1 (0.5%)
NPQ 5.6 1 (0.5%) 84.4 1 (0.5%)
COM 1.2 2 (0.9%) 5.0 1 (0.5%)
NDI and NPQ scores are given as % (range 0–100). COM scores are given as points (range 1–5).
Table 2: Values for VAS, NDI, NPQ, COM, CSQ, and SF-12*
Day 1 Day 15
nV a l u e nV a l u e
Neck pain (VAS), range 0–10 221 6.0 (4.0; 7.0) 221 5.0 (3.0; 7.0)
Referred pain (VAS), range 0–10 221 4.0 (0.0; 7.0) 221 3.0 (0.0; 6.0)
Disability (NDI), range 0–100 221 37.5 (26.0; 51.1) 221 31.1 (20.0; 44.4)
Disability (NPQ), range 0–100 221 38.9 (30.5; 54.6) 221 34.4 (20.6; 48.6)
Disability (COM), range 1–5 217 2.7 (2.4; 3.4) 215 2.4 (1.9; 3.0)
Catastrophizing (CSQ), range 0–36 218 12.0 (3.0; 18.0) 219 7.0 (0.0; 15.0)
Physical quality of life (PCSF-12), range 19.85 to 56.71 215 35.4 (30.6; 43.0) 214 39.0 (33.2; 48.0)
Mental quality of life (MCSF-12), range 14.15 to 68.45 215 41.6 (29.7; 54.6) 214 45.7 (31.1; 55.0)
*: Data given as median (P25, P75)BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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Effect size of NDI, NPQ and COM for patients having
worsened, not changed or improved according to external
criteria for pain and disability are shown in Tables 7 and
8. As seen in those tables, the effect sizes of NDI and NPQ
are consistent in showing moderate improvements in
patients having actually improved according to the exter-
nal criterion, while the effect size of COM magnifies the
amount of that improvement. As to patients reporting to
have actually worsened, the effect size of NDI shows a
small change consistent with that external criterion, while
the one of NPQ is close to the cut-off point for small
change and the COM does not detect any change. The
same trends are observed for results on pain (Table 6).
Tables 7 and 8 show correlation among the scores of the
VAS for NP, VAS for referred pain, NDI, COM and NPQ,
CSQ, and SF-12 (Physical and Mental). As seen in those
tables, on days 1 and 15 correlations among NDI, NPQ,
COM, VAS, CSQ. PCS-SF12 and MCS-SF12 (Physical and
Mental) were significant at the p < 0.001 level, except for
the one between MCS-SF12 and VAS for referred pain on
day 1, and MCS-SF12 and PCS-SF12 on days 1 and 15.
Correlations of NDI and NPQ with the rest of the scales
were similar and consistently stronger than correlations of
COM. Correlations between NDI and NPQ were 0.84 on
day 1 and 0.91 on day 15, whereas correlations between
COM and NPQ were 0.63 on day 1 and 0.71 on day 15.
Discussion
Results from this study show that the Spanish versions of
both NDI and COM are comprehensible and appropriate
instruments. In addition, they show that NDI, NPQ and
COM are internally consistent and valid instruments to
measure neck pain patients' disability, that floor and ceil-
ing effects are not a major concern for any of those ques-
tionnaires and that they can be used in routine clinical
conditions. In fact, this study was performed in routine
conditions, no patient left the NDI and NPQ question-
naires unanswered, and only 4 out of 221 (1.8%) left the
COM unanswered (Table 2).
According to results from this study, NDI is more effective
than NPQ and COM to assess neck pain disability. It is
reliable and shows the highest correlations with results
from instruments to measure pain, disability and quality
of life. In addition, it is the only questionnaire for which
the evolution of its score is consistent with external crite-
ria for pain and disability (Tables 4 and 5) and for which
effect sizes for pain and disability are consistent with
patients' assessment of their own clinical evolution (Table
6). According to these results, NPQ is the second best and
COM is the worst. NPQ does not detect worsening in dis-
ability and it suggests pain improvement in patients deny-
ing such an improvement (Table 6). Although internal
validity is similar for all the questionnaires and differ-
ences in correlation and reliability are small, COM is less
reliable than NDI, and its correlations with all the other
scales and questionnaires are lower than those for both
NDI and NPQ. In addition, COM is insensitive to worsen-
ing for both pain and disability, it reflects improvement in
pain for patients denying any change, and it magnifies the
amount of improvement for pain and, especially, disabil-
ity (Table 6). This implies that using the COM may lead to
the evolution of patients appearing to be more positive
than it actually is. The inferiority of COM to assess pain
and disability may be due to its global score being influ-
enced by patients' assessment of function, well being,
absenteeism and satisfaction, as opposed to the scores of
NDI and NPQ, which only focus on pain and disability.
Filling out the NDI requires two minutes more than
answering the COM. However, both questionnaires can
be appropriately filled out by the patient in the waiting
room without assistance, so this aspect is not a major
Table 5: Values of NDI, NPQ and COM across categories for external criteria for disability*
External criterion for disability* No disability Mild Moderate Severe Very severe
N 7 56 82 59 16
NDI 18.0 (12.0; 46.0) 27.3 (20.0; 35.5) 40.0 (28.0; 47.0) 44.0 (30.0; 60.0) 70.5 (58.5; 76.0)
NPQ 22.2 (13.9; 41.7) 30.5 (25.0; 37.1) 38.9 (33.3; 53.1) 47.2 (38.9; 62.5) 69.0 (54.8; 77.1)
COM 2.4 (1.6; 2.6) 2.5 (2.0; 2.9) 2.7 (2.4; 3.2) 3.0 (2.6; 3.7) 3.6 (3.1; 4.0)
*: Values are given as median (P25, P75). NDI and NPQ scores are given as % (range 0–100). COM scores are given as points (range 1–5).
Table 4: Values of NDI, NPQ and COM across categories for external criteria for pain*
External criterion for pain* No pain Mild pain Moderate pain Severe pain Very severe pain
N 7 74 83 49 8
NDI 22.0 (18.0; 37.8) 30.0 (23.5; 38.0) 36.0 (26.7; 46.0) 56.0 (43.1; 69.4) 61.0 (51.7; 79.0)
NPQ 22.2 (11.1; 33.3) 33.3 (25.0; 41.7) 38.9 (32.1; 50.0) 55.5 (42.7; 69.1) 55.5 (44.6; 74.1)
COM 2.0 (1.6; 3.1) 2.6 (2.2; 3.0) 2.6 (2.4; 3.1) 3.4 (2.7; 3.8) 3.2 (3.0; 3.7)
*: Values are given as median (P25, P75). NDI and NPQ scores are given as % (range 0–100). COM scores are given as points (range 1–5).BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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shortcoming for its use in routine practice. The time
needed to score the questionnaires was not measured in
this study, but physicians' feeling is that it is roughly sim-
ilar for all of the questionnaires: NDI and NPQ are longer
but scoring the COM is more complex, since it requires
the reversal of the order of answers to questions No. 3 and
6, and to calculate the mean value of the answers to the 7
items in order to get the final score.
Those characteristics may help to select the questionnaire
that is most suitable for use in a particular setting. When-
ever possible, the NDI seems to be the best option, espe-
cially in research settings where reliability, validity,
Table 7: Spearman Correlation Coefficients between NDI, COM, NPQ, VAS, CSQ, and SF-12 (Day 1).
VAS (referred pain) CSQ NDI NPQ Physical Component Summary 
(PCS-12)
Mental Component Summary 
(MCS-12)
COM
VAS (NP) 0.485 0.403 0.480 0.471 -0.246 -0.221 0.356
P 0.000 0.000 0.000 0.000 0.000 0.001 0.000
N 221 218 221 221 215 215 217
VAS (referred pain) 0.392 0.358 0.442 -0.431 -0.081 0.459
P 0.000 0.000 0.000 0.000 0.238 0.000
N 218 221 221 215 215 217
CSQ 0.482 0.452 -0.302 -0.369 0.369
P 0.000 0.000 0.000 0.000 0.000
N 218 218 214 214 214
NDI 0.844 -0.404 -0.498 0.610
P 0.000 0.000 0.000 0.000
N 221 215 215 217
NPQ -0.458 -0.402 0.628
P 0.000 0.000 0.000
N 215 215 217
Physical Component Summary 
(PCS-12)
-0.118 -0.477
P 0.085 0.000
N 215 212
Mental Component Summary 
(MCS-12)
-0.379
P 0.000
N 212
Table 6: Effect size of NDI, NPQ and COM for patients having worsened, not changed or improved between days 1 and 16, according 
to external criteria for pain and disability.
Scale Patients' status according to external criterion for disability N* Mean SD Effect Size**
NDI Worsened 29 -4.34 17.98 -0.24
Unchanged 80 2.46 16.07 0.15
Improved 111 12.20 18.52 0.66
NPQ Worsened 29 -2.58 18.13 -0.14
Unchanged 80 1.02 16.18 0.06
Improved 111 11.69 17.51 0.67
COM Worsened 26 0.04 0.89 0.05
Unchanged 79 0.13 0.70 0.19
Improved 106 0.63 0.69 0.92
Scale Patients' status according to external criterion for pain N* Mean SD Effect Size**
NDI Worsened 35 -4.05 16.21 -0.25
Unchanged 82 4.02 17.54 0.13
Improved 103 12.01 17.96 0.67
NPQ Worsened 35 -5.17 19.36 -0.27
Unchanged 82 3.21 17.02 0.19
Improved 103 11.86 16.57 0.72
COM Worsened 32 -0.02 0.75 -0.02
Unchanged 78 0.25 0.66 0.38
Improved 101 0.60 0.75 0.79
*: Total number of patients participating in the study was 221. Missing patients in these tables are due to missing values in either the questionnaire (NDI, NPQ or COM) or 
the external criterion for pain or disability
** Absolute values for effect size should be interpreted as follows: values < 0.20 correspond to no change, 0.20–0.49 to a small change, 0.50 to 0.79 to a moderate change and 
≥ 0.80 to a great change.21–23BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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sensitivity to changes and getting results that match actual
patients' perceptions are essential concerns. In addition,
the NDI is already available in several languages [6-10],
and considering one questionnaire as an international
standard could boost the implementation of disability
assessment of neck pain patients as a routine procedure in
clinical practice, and would help to compare results in
studies conducted in different settings. However, since it
might be better to use the COM than not to assess NP-
related disability at all, this questionnaire might also be
an option to consider in clinical environments where sav-
ing two minutes in the waiting room may make a differ-
ence. However, users of the COM should be aware that the
results they will get are likely to overestimate patients'
improvement and may not detect actual worsening.
Reliability was measured in the pilot study on the same
day, by giving the patient two different versions of the
NDI and COM questionnaires. The interval after which
the second version is to be given is a relevant decision; a
too long interval may underestimate reliability by allow-
ing actual changes in patients' degree of disability to
occur, while a too short interval may overestimate it
because of recall bias. At the design phase, it was decided
to give both versions on the same day, and to implement
measures to prevent recall bias. To that end, an interval of
at least 30 minutes lapsed between both tests, and the
patients were asked to fill out the VAS, NPQ, CSQ and SF-
12 questionnaires in the meantime. In addition, the sec-
ond version of both questionnaires had a different name
at the top ("NID" instead of "NDI", "CSC6" instead of
"COM"), the first version was taken once answered and
before handing out the second one, and both versions
listed the questions in a different order. Although the
change in the order of the questions might alter the
results, because a patient may consider a previous ques-
tion when answering the next, it was felt that this risk was
worthwhile in order to avoid recall bias. This method for
testing reliability had previously proven feasible and valid
in our environment [29-31]. In fact, none of the patients
identified the NDI and the NID, or the COM and the
CSC6, as being the same, suggesting that the measures
undertaken to avoid recall bias worked well. In addition,
in spite of the potential effect of the different order of the
questions in the NID and CSC6, intraclass correlation
coefficients, kappa values and results from the Bland-Alt-
man method showed a good reliability for NDI and COM.
Therefore, the reliability of these questionnaires should
not be a concern.
In some previous studies, patients' subjective classifica-
tion of their clinical evolution during the study period has
been used as the external criterion [32-36]. That approach
makes sense in studies where patients' subjective percep-
tion of evolution is to be considered the "gold standard",
such as those focusing on estimating the size of minimal
clinically important changes (MCIC) [32-36]. However, it
requires for patients to compare their current state at the
end of the study period with their recall of the initial one,
which is controversial [32,33]. At the design phase, it was
felt that such an approach might not be the most suitable
for this study, since relying on patients' memory might
have led to identifying only those changes that would
have been clinically meaningful for patients, and there-
Table 8: Spearman Correlation Coefficients between NDI0, COM, NPQ, VAS, CSQ, and SF-12 (Day 15).
VAS (referred pain) CSQ NDI NPQ Physical Component Summary 
(PCS-12)
Mental Component Summary 
(MCS-12)
COM
VAS (NP) 0.519 0.584 0.697 0.699 -0.458 -0.274 0.610
P 0.000 0.000 0.000 0.000 0.000 0.000 0.000
n 221 219 221 221 214 214 215
VAS (referred pain) 0.384 0.468 0.489 -0.427 -0.170 0.458
P 0.000 0.000 0.000 0.000 0.013 0.000
n 219 221 221 214 214 215
CSQ 0.667 0.669 -0.536 -0.357 0.567
P 0.000 0.000 0.000 0.000 0.000
n 219 219 212 212 213
NDI 0.908 -0.574 -0.409 0.693
P 0.000 0.000 0.000 0.000
n 221 214 214 215
NPQ -0.611 -0.380 0.706
P 0.000 0.000 0.000
n 214 214 215
Physical Component Summary 
(PCS-12)
-0.046 -0.594
P 0.503 0.000
n 214 210
Mental Component Summary 
(MCS-12)
-0.326
P 0.000
n 210BMC Musculoskeletal Disorders 2008, 9:42 http://www.biomedcentral.com/1471-2474/9/42
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fore to underestimate the validity of the questionnaires
that were being assessed. For that reason, in this study,
patients' subjective classification of their current level of
pain and disability at each assessment was used as the
external criterion, and it was used to assess their matching
with the scores on the NDI, NPQ and COM at that very
moment (Tables 4 and 5). Consequently, to assess
responsiveness to change, the change in scores of NDI,
NPQ and COM from baseline to final assessment was
explored for patients whose pain and disability had
improved, remained unchanged or worsened according to
their subjective classification at those assessments (Table
6).
For the NDI and NPQ, scores of items not applicable in
one particular patient (e.g., driving or reading) are homo-
geneously distributed among the other dimensions. From
the theoretical point of view, this might question the
validity of comparisons among patients in which different
dimensions are applicable. However, this is a common
feature in the Oswestry Disability Index (ODI), from
which both questionnaires derive, and previous studies
have shown those questionnaires to be valid and reliable
[3,4,14].
The representativity of the sample is not a major concern.
Participants were recruited in 9 different Spanish regions
representing the entire cultural and economic spectrum of
the country, both in the primary care and hospital setting,
and the sample included acute, subacute and chronic
patients with symptoms ranging from very mild to very
severe (Tables 1 and 2).
The National Spanish Academy of the Language is a multi-
national agency integrated by both Castillian and Mexican
experts in Spanish. It ensures that academic language, dic-
tionaries, and semantic and grammatical rules are homo-
geneous throughout the Spanish speaking world.
Therefore, these versions of the NDI and COM question-
naires may be used in any Spanish speaking country,
although some minor finetuning may be necessary in
order to adapt it to the specific terms that may be more
commonly used in informal language in some specific
cultural environments.
Conclusion
In conclusion, this study shows that the Spanish versions
of both NDI and COM are comprehensible and reliable,
that Spanish versions of NDI, NPQ and COM are inter-
nally consistent and valid, and that it is feasible to use any
of those questionnaires in routine practice. In addition,
they show that NDI is the most sensitive to change and the
only questionnaire to reflect patients' evolution according
to their own perception. This suggests that NDI is the best
option to measure NP-related disability. It requires two
more minutes than the COM to fill out, but it can be
answered by the patient in the waiting room without
assistance.
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